Coeptis Therapeutics Holdings, Inc. - Common Stock (NQ:COEP)

11.96 -0.08 (-0.63%)

Streaming Delayed Price Updated: 2:36 PM EDT, Mar 16, 2026 Add to My Watchlist

Price and Volume

Volume	29,575
Open	12.13
Bid (Size)	11.80 (1,000)
Ask (Size)	12.08 (200)
Prev. Close	12.04
Today's Range	11.74 - 12.15
52wk Range	6.260 - 21.41
Shares Outstanding	5,340,111
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Vanderbilt Report: Coeptis / Z Squared Merger Enters Final Stretch - Closing Imminent as Institutional Tailwinds Build

March 09, 2026

Via ACCESS Newswire

Coeptis Receives Shareholder Approval Towards Z Squared Merger

February 05, 2026

Shareholder Approval Clears a Key Condition to Close

From Coeptis Therapeutics

Via GlobeNewswire

Performance

YTD	-18.3%	-18.3%
1 Month	-1.2%	-1.2%
3 Month	-20.7%	-20.7%
6 Month	-6.5%	-6.5%
1 Year	+40.8%	+40.8%

More News

Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared

January 06, 2026

From Coeptis Therapeutics

Via GlobeNewswire

Three Biotech Companies Redefining Value Creation Through Dual Strategies

October 14, 2025

Via ACCESS Newswire

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates BFIN, COEP, ARIS, CIO on Behalf of Shareholders

October 07, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Coeptis Anchors $800M Valuation in Dual-Sector Strategy; Vanderbilt Report Publishes Coverage

October 01, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 24, 2025

Via Benzinga

Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd

July 22, 2025

From Coeptis Therapeutics

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, COEP, AVDX on Behalf of Shareholders

July 05, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared

June 26, 2025

From Coeptis Therapeutics

Via GlobeNewswire

Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology

May 28, 2025

From Coeptis Therapeutics

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Skechers U.S.A., Inc. (NYSE - SKX), BioSig Technologies, Inc. (Nasdaq – BSGM), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.

May 05, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COEP and PPBI on Behalf of Shareholders

May 01, 2025

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.

May 01, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 30, 2025

Via Benzinga

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COEP, SWTX, CKPT on Behalf of Shareholders

April 30, 2025

From Halper Sadeh LLC

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 25, 2025

Via Benzinga

Crude Oil Edges Higher; Phillips 66 Posts Wider-Than-Expected Loss ↗

April 25, 2025

Via Benzinga

COEP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Coeptis Therapeutics Holdings, Inc. Is Fair to Shareholders

April 25, 2025

From Halper Sadeh LLC

Via Business Wire

Dow Falls 200 Points; Alphabet Posts Upbeat Q1 Results ↗

April 25, 2025

Via Benzinga

Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement

April 25, 2025

From Coeptis Therapeutics

Via GlobeNewswire

COEPTIS (COEP) Expands Global Footprint with Strategic India Tech Hub

April 22, 2025

Via AB Newswire

COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology

April 17, 2025

From Coeptis Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 24, 2025

Via Benzinga

Top movers in Monday's after hours session ↗

March 17, 2025

Via Chartmill

Frequently Asked Questions

Is Coeptis Therapeutics Holdings, Inc. - Common Stock publicly traded?

Yes, Coeptis Therapeutics Holdings, Inc. - Common Stock is publicly traded.

What exchange does Coeptis Therapeutics Holdings, Inc. - Common Stock trade on?

Coeptis Therapeutics Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Coeptis Therapeutics Holdings, Inc. - Common Stock?

The ticker symbol for Coeptis Therapeutics Holdings, Inc. - Common Stock is COEP on the Nasdaq Stock Market

What is the current price of Coeptis Therapeutics Holdings, Inc. - Common Stock?

The current price of Coeptis Therapeutics Holdings, Inc. - Common Stock is 11.96

When was Coeptis Therapeutics Holdings, Inc. - Common Stock last traded?

The last trade of Coeptis Therapeutics Holdings, Inc. - Common Stock was at 03/16/26 02:36 PM ET

What is the market capitalization of Coeptis Therapeutics Holdings, Inc. - Common Stock?

The market capitalization of Coeptis Therapeutics Holdings, Inc. - Common Stock is 63.89M

How many shares of Coeptis Therapeutics Holdings, Inc. - Common Stock are outstanding?

Coeptis Therapeutics Holdings, Inc. - Common Stock has 64M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.